SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 237 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $684,000 | -85.6% | 23,643 | -84.0% | 0.00% | -86.7% |
| Q1 2022 | $4,766,000 | +985.6% | 147,469 | +698.2% | 0.02% | +275.0% |
| Q2 2020 | $439,000 | +45.8% | 18,475 | +10.5% | 0.00% | 0.0% |
| Q1 2020 | $301,000 | -26.8% | 16,716 | -3.5% | 0.00% | +100.0% |
| Q4 2019 | $411,000 | +70.5% | 17,320 | +330.4% | 0.00% | +100.0% |
| Q2 2018 | $241,000 | -2.4% | 4,024 | -25.5% | 0.00% | 0.0% |
| Q1 2018 | $247,000 | -95.8% | 5,399 | -96.3% | 0.00% | -95.7% |
| Q3 2017 | $5,825,000 | +2727.7% | 145,625 | +2940.8% | 0.02% | +2200.0% |
| Q2 2017 | $206,000 | -92.5% | 4,789 | -95.7% | 0.00% | -93.8% |
| Q3 2016 | $2,741,000 | – | 110,847 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |